CD14 and Miyoshi myopathy: All cohort analyses of MM and SMM patients showed CD14 + CD16 + nonclassical monocytes express higher levels of PD‐L1 than classical CD14 + CD16 ‐ cells, and it was unrelated to the disease stage.25